Status:

COMPLETED

Evaluation of an Education Program to Increase Knowledge and Participation in Clinical Trials Among Racial/Ethnic and Rural Populations

Lead Sponsor:

Ohio State University Comprehensive Cancer Center

Conditions:

Hematopoietic and Lymphoid System Neoplasm

Malignant Solid Neoplasm

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This clinical trial evaluates a culturally tailored educational outreach intervention for increasing clinical trial knowledge, referral, and participation among racial/ethnic minority and rural popula...

Detailed Description

PRIMARY OBJECTIVE: I. To implement culturally tailored educational outreach activities with the goal of increasing clinical trial (CT) knowledge, referral and participation among racial/ethnic and ru...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Adult males and females 18 years of age and older from Ohio
  • Will not let anyone who is not cognitively able to give voluntary informed consent take part in the education sessions

Exclusion

    Key Trial Info

    Start Date :

    August 15 2022

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2024

    Estimated Enrollment :

    78 Patients enrolled

    Trial Details

    Trial ID

    NCT06112002

    Start Date

    August 15 2022

    End Date

    December 31 2024

    Last Update

    January 28 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States, 43210